Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04236908 · ClinicalTrials.gov registry record · NA
Accessible Acupuncture for the Warrior With Acute Low Back Pain
A NA study, sponsored by David Moss.
- Completed
- Registry status
- NA
- Development phase
- 276
- Enrollment target
NCT04236908: Completed NA study, sponsored by David Moss.
NCT04236908 is a NA study that has completed, run by David Moss. The registered enrollment target is 276 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04236908, a NA study, has completed, sponsored by David Moss.
- COMPLETED
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
Study Summary
The objective of this study is to determine if auricular acupuncture and/or the acupuncture point governor vessel 26 (GV26) with manual tonification is superior to conservative management (NSAIDs) at reducing acute low back pain (less than 4 weeks in duration).
Primary Outcome
The DVPRS consists of an 11-point numerical rating scale with 0 indicating no pain and 10 indicating severe pain. It has been confirmed for reliability and validity in measuring both acute and chronic pain, and is currently the standard for pain measurement throughout DoD and VA health systems. The DVPRS has demonstrated linear scale qualities allowing parametric methods to be used.
Interventions
- DRUG NSAIDS
- DEVICE Battlefield Acupuncture
- DEVICE GV26 with manual tonification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2025-12-09 |
| Phase | NA |
What the finished NCT04236908 record still lists
NCT04236908 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 3 interventions - of which NSAIDS is the first listed.
NCT04236908 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04236908 about?
NCT04236908 is a clinical study titled "Accessible Acupuncture for the Warrior With Acute Low Back Pain". The objective of this study is to determine if auricular acupuncture and/or the acupuncture point governor vessel 26 (GV26) with manual tonification is superior to conservative management (NSAIDs) at reducing acute low back pain (less than 4 weeks in duration).
What is the current status of trial NCT04236908?
This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2020-08-25. Estimated completion is 2025-12-09.
What interventions are being tested in trial NCT04236908?
The interventions under investigation include: NSAIDS (DRUG), Battlefield Acupuncture (DEVICE), GV26 with manual tonification (DEVICE).
Who is sponsoring clinical trial NCT04236908?
This trial is sponsored by David Moss, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04236908's enrollment target sits among peer trials
276 383rd of 2000 higher than 1,618 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI